Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 6 studies | 21% ± 5% | |
macrophage | 6 studies | 30% ± 5% | |
endothelial cell | 5 studies | 25% ± 8% | |
myeloid cell | 5 studies | 20% ± 3% | |
epithelial cell | 4 studies | 27% ± 6% | |
glutamatergic neuron | 4 studies | 39% ± 12% | |
monocyte | 4 studies | 24% ± 5% | |
ciliated cell | 3 studies | 23% ± 4% | |
GABAergic neuron | 3 studies | 41% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 6% | |
interneuron | 3 studies | 36% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 706.31 | 1442 / 1445 | 100% | 16.45 | 183 / 183 |
lung | 99% | 802.10 | 575 / 578 | 100% | 10.31 | 1153 / 1155 |
breast | 100% | 751.84 | 459 / 459 | 98% | 10.09 | 1097 / 1118 |
brain | 99% | 507.04 | 2626 / 2642 | 98% | 8.31 | 694 / 705 |
thymus | 100% | 619.24 | 652 / 653 | 98% | 6.84 | 591 / 605 |
pancreas | 99% | 387.52 | 325 / 328 | 98% | 6.50 | 175 / 178 |
uterus | 100% | 407.21 | 170 / 170 | 97% | 8.89 | 445 / 459 |
intestine | 100% | 722.73 | 965 / 966 | 97% | 10.41 | 511 / 527 |
stomach | 99% | 390.84 | 357 / 359 | 97% | 11.24 | 277 / 286 |
ovary | 99% | 348.53 | 179 / 180 | 96% | 6.00 | 414 / 430 |
bladder | 100% | 559.86 | 21 / 21 | 96% | 7.82 | 482 / 504 |
adrenal gland | 100% | 441.02 | 258 / 258 | 92% | 5.47 | 212 / 230 |
prostate | 100% | 387.67 | 245 / 245 | 92% | 5.11 | 461 / 502 |
kidney | 99% | 396.69 | 88 / 89 | 93% | 9.50 | 836 / 901 |
skin | 100% | 1055.71 | 1807 / 1809 | 85% | 5.09 | 400 / 472 |
liver | 100% | 519.11 | 226 / 226 | 82% | 3.89 | 331 / 406 |
adipose | 100% | 957.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 773.67 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.66 | 1 / 1 |
blood vessel | 99% | 496.15 | 1325 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 477.48 | 792 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.70 | 44 / 45 |
peripheral blood | 96% | 1172.29 | 894 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 6.16 | 27 / 29 |
heart | 91% | 331.14 | 783 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 1.67 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046488 | Biological process | phosphatidylinositol metabolic process |
GO_0032958 | Biological process | inositol phosphate biosynthetic process |
GO_0043647 | Biological process | inositol phosphate metabolic process |
GO_0070266 | Biological process | necroptotic process |
GO_0032957 | Biological process | inositol trisphosphate metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000825 | Molecular function | inositol tetrakisphosphate 6-kinase activity |
GO_0051765 | Molecular function | inositol tetrakisphosphate kinase activity |
GO_0008440 | Molecular function | inositol-1,4,5-trisphosphate 3-kinase activity |
GO_0000824 | Molecular function | inositol tetrakisphosphate 3-kinase activity |
GO_0047326 | Molecular function | inositol tetrakisphosphate 5-kinase activity |
GO_0102732 | Molecular function | myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity |
GO_0000823 | Molecular function | inositol-1,4,5-trisphosphate 6-kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0097243 | Molecular function | flavonoid binding |
GO_0005515 | Molecular function | protein binding |
GO_0046934 | Molecular function | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene name | IPMK |
Protein name | Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase) |
Synonyms | IMPK |
Description | FUNCTION: Inositol phosphate kinase with a broad substrate specificity . Phosphorylates inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) first to inositol 1,3,4,5-tetrakisphosphate and then to inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) . Phosphorylates inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4) . Phosphorylates inositol 1,4,5,6-tetrakisphosphate (Ins(1,4,5,6)P4) (By similarity). Phosphorylates glycero-3-phospho-1D-myo-inositol 4,5-bisphosphate to glycero-3-phospho-1D-myo-inositol 3,4,5-trisphosphate . Plays an important role in MLKL-mediated necroptosis via its role in the biosynthesis of inositol pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6). Binding of these highly phosphorylated inositol phosphates to MLKL mediates the release of an N-terminal auto-inhibitory region, leading to activation of the kinase. Essential for activated phospho-MLKL to oligomerize and localize to the cell membrane during necroptosis . Required for normal embryonic development, probably via its role in the biosynthesis of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) and inositol hexakisphosphate (InsP6) (By similarity). . |
Accessions | Q8NFU5 ENST00000373935.4 |